The role of HIV in serious diseases other than AIDS
HIV clinical trial design for antiretroviral development: moving forward
Mitochondrial DNA haplogroups influence AIDS progression
The effect of antiretroviral treatment of different durations in primary HIV infection
HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency
Transmission networks of drug resistance acquired in primary/early stage HIV infection
Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil
Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin
Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies
Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy
HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro
Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa
Efavirenz–rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patients
How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy?
Raltegravir for postexposure prophylaxis following occupational exposure to HIV
Controlling the HIV epidemic, without a vaccine!
The involvement of men within prenatal HIV counselling and testing. Facts, constraints and hopes
Abacavir-induced hepatotoxicity: a report of two cases